Recruiting
Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
NCT06395285
- Conditions
- Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Duke Eye Center - Duke University Hospital Durham, North Carolina, United States
- John A. Moran Eye Center - University of Utah Health Salt Lake City, Utah, United States
- Save Sight Institute - University of Sydney Eye Hospital Sydney, New South Wales, Australia